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Abstract
Epidemiologic studies suggest that occupational exposure to pesticides might increase Parkinson 
disease risk. Some pesticides, such as the organophosphorus insecticide chlorpyrifos, appear to 
increase the expression of α-synuclein, a protein critically involved in Parkinson disease. 
Therefore, we assessed total blood cell α-synuclein in 90 specimens from 63 agricultural pesticide 
handlers, mainly Hispanic men from central Washington State, who participated in the state’s 
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cholinesterase monitoring program in 2007–2010. Additionally, in age-adjusted linear regression 
models for repeated measures, we assessed whether α-synuclein levels were associated with 
butyrylcholinesterase-chlorpyrifos adducts or cholinesterase inhibition measured in peripheral 
blood, or with self-reported pesticide exposure or paraoxonase (PON1) genotype. There was no 
evidence by any of those indicators that exposure to chlorpyrifos was associated with greater 
blood α-synuclein. We observed somewhat greater α-synuclein with the PON1 -108T (lower 
paraoxonase enzyme) allele, and with ≥10 hours of exposure to cholinesterase inhibiting 
insecticides in the preceding 30 days, but neither of these associations followed a clear dose-
response pattern. These results suggest that selected genetic and environmental factors may affect 
α-synuclein blood levels. However, longitudinal studies with larger numbers of pesticide handlers 
will be required to confirm and elucidate the possible associations observed in this exploratory 
cross-sectional study.
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1. Introduction
Parkinson disease (PD) is a progressive, neurodegenerative movement disorder that affects 
up to 2% of the population older than age 60 (Elbaz et al. 2002; Wright Willis et al. 2010). 
The signs of PD, which include slow movement, tremor, rigidity and postural impairment, 
result from the loss of dopaminergic neurons in the substantia nigra region in the midbrain. 
Both genetic and environmental factors are believed to contribute to the development of 
sporadic PD (Wirdefeldt et al. 2011b). Pesticides are among the environmental factors 
suspected to increase PD risk (Wirdefeldt et al. 2011a). A recent meta-analysis (Allen and 
Levy 2013) suggests a ≥34% increased risk of PD in relation to occupational exposure to 
either insecticides or herbicides. Notably, some pesticides appear to increase α-synuclein (α-
syn) in cell line models of dopaminergic neurons (Chorfa et al. 2013; Slotkin and Seidler 
2011). α-Syn is a protein that is critically involved in PD. It aggregates in the brain as the 
major component of Lewy bodies, a pathological hallmark of PD (Spillantini et al. 1997). 
Genetic mutations in SNCA, the gene coding for α-syn, are strongly associated with both 
familial and sporadic forms of the disease, notably including those that increase α-syn 
(Maraganore et al. 2006; Mata et al. 2010; Singleton et al. 2003). Lower methylation of the 
SNCA promoter, as has been observed among PD patients’ brains, is also associated with 
increased α-syn (Jowaed et al. 2010; Matsumoto et al. 2010).
Of the pesticides thus far associated with greater α-syn or SNCA expression in neurons, the 
one most commonly employed in agriculture (USDA 2013) is the organophosphorus 
insecticide chlorpyrifos (Slotkin and Seidler 2011). Therefore, we investigated the relation 
between α-syn and occupational chlorpyrifos exposure. We hypothesized that, among 
agricultural workers exposed to chlorpyrifos, α-syn would be increased among those with 
highest exposures. We tested this hypothesis in a population of actively working agricultural 
pesticide handlers in an apple-growing region of central Washington State in 2007–2010. 
We measured α-syn in peripheral blood cells, where the protein is observed at readily 
Nielsen et al. Page 2













detectable levels (e.g. 24,800 ng/mL, approximately one thousand times greater than levels 
in plasma) (Barbour et al. 2008). The extent to which blood and brain α-syn are correlated 
remains to be established directly. However, the SNCA Rep1 259 length allele, very well-
established as protective with regard to PD (Maraganore et al. 2006), is associated with 
lower SNCA expression or α-syn protein levels in humans in both the midbrain (Linnertz et 
al. 2009) and peripheral blood mononuclear cells (Fuchs et al. 2008) relative to longer 
alleles. When accounting for total protein content, α-syn levels in these cells are similar to 
the level in red blood cells (Barbour et al. 2008), where >98% of blood α-syn resides 
(Barbour et al. 2008; Shi et al. 2010). In addition, an SNCA gene triplication that increases 
risk of PD is estimated to double levels of α-syn in the blood (Miller et al. 2004).
2. Materials and Methods
2.1. Source and selection of specimens
We obtained lithium heparin-treated packed whole blood cells from a biorepository at the 
University of Washington Department of Environmental and Occupational Health Sciences 
(Seattle, WA). The biorepository contains blood samples collected during an earlier study of 
occupational and genetic determinants of serum cholinesterase inhibition in adult 
agricultural workers (Hofmann et al. 2009; Hofmann et al. 2010b). This study population is 
comprised mainly of Hispanic male pesticide handlers who had been recently exposed to 
cholinesterase inhibiting (organophosphorus and/or carbamate) insecticides for >30 hours in 
a 30 day period while working in tree fruit orchards in the Yakima Valley of central 
Washington State. Whole blood was originally collected from these workers by 
venipuncture into heparinized vacutainer tubes. It was then spun at 2,500 rpm to separate 
plasma and cells and then stored in separate cryovials in a refrigerator for up to three days 
before transfer to a −80°C freezer in the biorepository.
The present work is based on a sample of 128 specimens originally selected from the 
biorepository to assess the feasibility of using chlorpyrifos-butyrylcholinesterase (BuChE) 
adducts as a measure of chlorpyrifos exposure and cholinesterase inhibition (Riutta et al. 
2012). This sample, drawn from specimens obtained in the years 2007–2010, included 100 
selected from the repository at random. The other 28 were selected because they were from 
workers who had experienced cholinesterase depression in the previous two weeks 
(depressionary follow-up samples) or were in an earlier pilot study. Sufficient (>0.5 mL 
packed blood cells) remained to attempt the α-syn assay for 90 (70%) of the specimens, and 
α-syn was measured in all 90. Of those, 70 had been selected at random. Workers in the 
original study could have participated in more than one year, and could have provided 
multiple specimens in the same year if they experienced high levels of exposure or 
cholinesterase depression. Of the 90 specimens, 63 were from unique subjects, and 27 were 
repeat specimens collected from 18 subjects. Two-thirds of the pairs were collected in 
different years (18 pairs), five pairs 36–56 days apart, and four pairs one week apart.
The original studies and biorepository were approved by the University of Washington 
Institutional Review Board, which also provided an exemption for the present specimen-
based analysis. All subjects provided written informed consent to participate in the original 
study and to have their blood samples archived in the biorepository for future research.
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2.2 Assessment of blood α-syn
Whole blood cells were assayed for total α-syn (μg/mL) in random order on two plates with 
positive and negative controls following an established protocol (Hong et al. 2010; Shi et al. 
2010). Briefly, red blood cells were lysed and the diluted supernatant was incubated with α-
syn capture and detection antibodies, respectively rabbit anti-α-synuclein antibody (ASY-1, 
which largely recognizes the C-terminal of the protein) (Jensen et al. 2000) and biotinylated 
anti-human α-synuclein antibody (R&D systems, Minneapolis, MN, USA). We quantitated 
α-syn using a LiquiChip Luminex 200TM instrument (Qiagen, Valencia, CA, USA). The 
intra-assay coefficient of variation was 0.5%, and the inter-assay coefficient of variation was 
3%.
2.3 Assessment of chlorpyrifos exposure and other factors
We included both laboratory- and interview-based indicators of exposure to chlorpyrifos and 
related factors. Our primary exposure variable of interest was chlorpyrifos-BuChE adducts 
(Riutta et al. 2012). This is the percent BuChE with a monoethyl phosphate adduct 
(generated when chlorpyrifos attaches to BuChE and ages irreversibly) assessed by high-
performance liquid chromatography tandem mass spectrometry using 1.8 mL of whole 
blood. The limit of detection is at approximately 4% adducts. Also available were data on 
the percent change (relative to the subject’s pre-spray level) of red blood cell 
acetylcholinesterase (AChE) and serum BuChE activity from the State of Washington’s 
cholinesterase monitoring program (Wilson et al. 2009). In addition, we used Taqman 
detection system based assays to assess two functional PON1 single nucleotide 
polymorphisms, Q192R and C-108T. The PON1 gene codes for the enzyme paraoxonase, 
which detoxifies the activated intermediate (oxon) of chlorpyrifos. Chlorpyrifos-oxonase 
activity, which is influenced by the C-108T and Q192R polymorphisms, markedly affects 
susceptibility to chlorpyrifos (Costa et al. 2013). Paraoxonase also detoxifies the oxon of 
diazinon, which also was applied in apple orchards during the study years in Washington, 
though less widely (6–9% of bearing acres vs. 39–64% for chlorpyrifos).
In addition to these laboratory-based measures, data from interviews with the agricultural 
workers who provided the specimens were available for 82 (91%) of the specimens. These 
data had been collected via a computer-based questionnaire that the workers completed in 
person in Spanish or English (Hofmann et al. 2010a). The questionnaire assessed ethnicity, 
sex, tobacco smoking and work history, including total years handling agricultural 
pesticides, and the duration and type of cholinesterase inhibiting insecticides handled within 
the 30 days preceding collection of the associated blood sample. The questionnaire 
specifically inquired about 11 cholinesterase inhibiting insecticides. We report results for 
those reportedly handled by >5% of the participants within 30 days of blood collection: 
chlorpyrifos, azinphos-methyl and carbaryl. Study participants did not report using diazinon.
2.4 Statistical analysis
We used Stata version 11.1 (StataCorp, College Station, TX) for all statistical analysis. We 
conducted linear regression models suitable for repeated measures, specifically generalized 
linear models, with α-syn (μg/mL, continuous) as the outcome variable. We report β 
coefficients and 95% confidence intervals (CIs), characterizing the difference in α-syn levels 
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across strata of each of the variables of interest, while adjusting for age (continuous) because 
of its association with α-syn (Barbour et al. 2008; Shi et al. 2010). Among workers who 
completed the questionnaire, all but one was a Hispanic man, so we were unable to adjust 
for race, ethnicity and gender. We did not adjust for tobacco smoking or experimental plate 
because these changed the observed coefficients by <10%. We repeated all analyses while 
excluding the 20 specimens not selected at random, or excluding the specimens collected in 
2007. We conducted the latter sensitivity analyses because there were technical issues in the 
cholinesterase measurements for that year (WSDOSH 2007), and preliminary analyses 
indicated marked differences in α-syn in specimens from 2007 vs. other years. In a more 
exploratory separate analysis, we compared α-syn values between paired blood specimens to 
assess the extent to which blood α-syn changes over time within an individual.
3. Results
3.1 Characteristics of participants
Among participants who provided interview data, all but one was a Hispanic man (Table 1). 
Age when providing the first specimen ranged from 20 to 60 years (median 33 years). All 
participants had been handling pesticides for ≤ 15 years, with a majority (71%) handling 
pesticides for ≤5 years. The median blood α-syn was 79.0 μg/mL (range 33.6 to 126.5 
μg/mL; mean 77.5 μg/mL; standard deviation 18.9 μg/mL; not shown in tables).
3.2 Factors associated with blood α-syn
There was no indication that blood α-syn increased with increasing BuChE-chlorpyrifos 
adducts or with BuChE inhibition (Table 2). AChE inhibition was associated with greater 
blood α-syn (ptrend ≤ 0.05 overall and excluding year 2007), but this was due to a single 
worker with >20% AChE inhibition and blood α-syn at the 99th percentile. Self-reported 
exposure to chlorpyrifos or other commonly-reported cholinesterase inhibiting insecticides 
in the preceding 30 days also were not associated with blood α-syn. However, workers who 
reported they did not know what pesticides they used in the preceding 30 days had markedly 
greater blood α-syn compared to other workers (p=0.006; Table 2). This association was not 
attenuated by adjustment for level of experience, as there was no association between blood 
α-syn and total years handling pesticides after adjusting for age.
We observed no dose-response associations between blood α-syn and days since handling 
these pesticides, total number of hours handling them, or number of days handling them for 
>8 hours (Table 2). At the same time a possible threshold effect was suggested as blood α-
syn was generally greater among workers who had handled pesticides for ≥10 hours, 
compared to workers who had handled pesticides for <10 hours in the preceding 30 days. 
Blood α-syn was also greater in specimens collected in 2007 than in later years, and among 
carriers of the PON1 -108T allele (Table 2). There was no association between PON1 
Q192R genotype and blood α-syn, with or without adjustment for the C-108T 
polymorphism.
In a fuller multivariable model (Table 3), the above associations remained (all p≤0.02). 
These associations were insensitive to the exclusion of any individual specimen, and results 
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were also similar when we focused on the randomly selected specimens (data not shown in 
tables).
Because the association between α-syn and PON1 C-108T remained in the fuller model, we 
explored whether this association was modified by any indicator of chlorpyrifos exposure. 
The association between α-syn and PON1 C-108T did not clearly differ by recent 
chlorpyrifos exposure (self-reported exposure or chlorpyrifos-BuChE adducts, all interaction 
p-values >0.23, data not shown in tables). There also was no indication that the association 
was stronger in workers with the greatest number of years of exposure.
3.3 Blood α-syn in longitudinal specimens
When we explored the extent to which blood α-syn levels might change over time, we 
observed that in some instances there were marked fluctuations from year to year. These 
ranged from a 63% decline to an 80% increase from one year to the next in 18 paired 
samples, but on average there was little change. The largest decline was for a worker whose 
first specimen was from 2007, but a drop after 2007 was not universally observed. There 
also were marked fluctuations in blood α-syn within the same year: Among the specimen 
pairs taken in the same year because the worker reached the 30 hours of exposure in 30 days 
threshold a second time, three of four workers showed marked increases from the end of the 
first to the end of the second exposure period (73–115% increases in blood α-syn). Blood α-
syn did not clearly go up or down for the three additional workers (four pairs) whose same-
year blood specimens were taken only one week apart.
4. Discussion
To our knowledge this is the first study to assess α-syn, the hallmark protein of PD, in a 
cohort of workers occupationally exposed to pesticides. Our primary aim was to examine 
whether exposure to chlorpyrifos, as measured by BuChE-chlorpyrifos adducts, was 
positively associated with α-syn in blood cells. We found no evidence of this, nor of an 
association between blood α-syn and self-reported chlorpyrifos exposure. Similarly, there 
was no association between blood α-syn and BuChE inhibition, which is notable because 
chlorpyrifos more efficiently inhibits BuChE compared to AChE (Eaton et al. 2008). There 
also was no association between blood α-syn and the other two cholinesterase-inhibiting 
insecticides that we were able to consider, azinphos-methyl and carbaryl. Although our 
findings were thus generally negative for these types of pesticides, we did observe increased 
blood α-syn levels among those with the T allele at position -108 in the PON1 promoter 
region, the allele associated with lower levels of paraoxonase enzyme expression due to 
disruption of a transcription factor binding site (Deakin et al. 2003). This association may 
reflect the enzyme’s more generic anti-oxidant potential (Shih et al. 1998), rather than its 
ability to hydrolyze the oxons of chlorpyrifos and diazinon, given our negative results for 
chlorpyrifos and apparently limited exposure to diazinon. The absence of an association 
between α-syn and PON1 Q192R genotype, which is thought to influence the catalytic 
efficiency of chlorpyrifos oxon hydrolysis (Costa et al. 2013), underscores this possibility.
Our secondary analyses identified other potential indicators of pesticide exposure associated 
with greater α-syn in blood cells: Handling unknown pesticides in the preceding 30 days, 
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handling pesticides for ≥10 hours in the preceding 30 days, and providing a blood sample in 
2007 (vs. 2008–2010). Given the number of comparisons made, and our modest sample size, 
some or all of these secondary findings may be due to chance, particularly since dose-
response associations were not clearly present. In particular, we cannot account for the 
markedly greater blood α-syn in 2007 compared to later years. Despite compelling evidence 
that rotenone, paraquat and maneb may relate to increased α-syn and risk of PD (Bové and 
Perier 2012; Chorfa et al. 2013; Pan-Montojo et al. 2010; Pezzoli and Cereda 2013; Tanner 
et al. 2011), there do not appear to have been year-to-year changes in the use of these or 
similar compounds that might explain the year to year changes in a-syn that we observed 
(USDA 2013). Paraquat and mancozeb (manganese-containing fungicide like maneb) were 
each applied to 11–16% of acres producing apples in Washington State during the study 
years, while neither rotenone nor maneb were individually listed in this survey in any 
relevant survey years (2007, 2009 or 2011; no survey data for 2008 or 2010). Because none 
of these four pesticides were included on our questionnaire, which focused on cholinesterase 
inhibitors, we were unable to directly evaluate their potential effect on blood α-syn. This is a 
limitation, as is our inability to consider some combined measure of total pesticide exposure, 
or perhaps a more biologically relevant measure (e.g. total oxidative stress potential). 
However, there were marked changes in use of other pesticides between 2007 as compared 
to all later survey years (2009 and 2011). These include reductions in the proportion of apple 
acres treated with chlorpyrifos and azinphos-methyl, and commensurate increases for some 
insect pheromones and the neonicotinoid insecticides imadacloprid and thiacloprid (USDA 
2013). Changes were not limited to insecticides, however. For example, the portion treated 
with any herbicide dropped from 61% in 2007 to 40–43% in 2009 and 2011, and the use of 
sulfur as a fungicide increased from 30% in 2007 to 47–48% in 2009 and 2011 despite slight 
decreases in the total portion of acres treated with fungicides.
The finding that blood α-syn was greater in workers who handled pesticide(s) that they 
could not specify could indicate that blood α-syn might be affected by any number of 
pesticides, even those not registered for use on apples in 2007–2010. However, we speculate 
that a lack of knowledge about what pesticide was recently applied also may indicate less 
rigorous use of personal protective equipment. Although we were unable to examine the 
association between α-syn and the use of personal protective equipment, we were able to 
consider data on the pesticide handlers’ years of experience, and that was unrelated to α-syn.
Our exploratory analysis of blood α-syn changes over time suggested that blood α-syn can 
fluctuate markedly within an individual. Notably, three of four workers experienced 
substantial increases during the course of the spray season. To our knowledge, longitudinal 
changes in blood α-syn have not been previously examined. Therefore, this observation 
must be interpreted with caution given the very small number of paired samples available 
for this analysis. Moreover, all of our findings, including this one, remain somewhat difficult 
to interpret with regard to PD because as noted above, it is unknown the extent to which 
blood α-syn indicates α-syn levels in the brain or PD risk.
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Some pesticide exposures or susceptibility factors may affect α-syn levels in blood cells, but 
we observed little evidence that chlorpyrifos or other cholinesterase inhibitors increase 
blood α-syn in this contemporary sample of workers in the U.S. with little cholinesterase 
depression. Longitudinal studies in a larger sample of more highly exposed workers in 
which pre- and post-spray α-syn levels are measured in blood will be needed to confirm our 
largely negative findings, and explore the few positive findings suggested. Ideally, future 
epidemiologic studies should be designed to also test the hypothesis that other pesticides, 
such as rotenone, maneb, mancozeb and paraquat, or combinations of pesticides, increase α-
syn concentrations in blood and to the extent possible within the brain as well. These 
investigations may help identify what occupational factors among pesticide handlers might 
increase PD risk, which also could have implications for risk among the general public with 
potential exposure to agricultural pesticides.
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• We assess α-synuclein in blood from active agricultural pesticide handlers
• Blood α-synuclein is not associated with butyrylcholinesterase-chlorpyrifos 
adducts
• Blood α-synuclein is not associated with other indicators of chlorpyrifos 
exposure
• Blood α-synuclein is associated with paraoxonase genotype
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Table 1








Male -- 57 (100)
Hispanic -- 56 (98)
Educated in Mexico -- 53 (96)a
Age first provided a specimen, years
 Range 20–60 20–60
 Median 33 33
 Mean (standard deviation) 34.5 (9.1) 33.9 (8.8)
Years handling pesticidesa
 ≤1 -- 15 (27)
 2–3 -- 13 (24)
 4–5 -- 11 (20)
 6–10 -- 13 (24)
 11–15 -- 3 (5)
Year first provided a specimen
 2007 11 (17) 8 (14)
 2008 26 (41) 25 (44)
 2009 16 (25) 14 (25)
 2010 10 (16) 10 (18)
a
Percent excludes 2 without data on smoking, education and years handling pesticides
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Table 3
Predictors of blood α-synuclein among agricultural pesticide handlers, central Washington State, 2007–2010
Mutually-adjusted relative mean α-synuclein in μg/mL (95% CI)a
N=90 p-value
Used unknown (vs. specified) pesticidesb 19.4 (5.1, 33.7) 0.008
Handled insecticides ≥10 (vs. <10) hoursb 14.7 (4.3, 25.2) 0.006
Year 2007 (vs. 2008–2010) 18.7 (7.0, 30.4) 0.002
PON1 C-108T (per T allele)c 5.7 (0.8, 10.6) 0.02
Pesticide handler age (per year) 0.3 (−0.1, 0.6) 0.13
a
Also adjusted for no interview data on hours and/or type of pesticides in preceding 30 days, to allow the inclusion of all specimens in the 
mutually-adjusted model
b
In preceding 30 days
c
Modeled linearly (0, 1 or 2 T alleles) as indicated as appropriate according to likelihood ratio test; estimate shown is per allele (i.e. CT vs. CC, and 
TT vs. CT); accordingly the estimate for TT vs. CC is 11.5 (95% CI 1.7, 21.2)
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